Income Statement (TTM)
Speed Medical Co - Equity Right Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2023 03-31 |
2023 06-30 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
|
|---|---|---|---|---|---|
| Revenue | 92 | 65 | 57 | 54 | 55 |
| Change (%) | -29.92 | -12.50 | -5.25 | 1.97 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 121 | 99 | 81 | 81 | 79 |
| Change (%) | -17.71 | -18.88 | 0.43 | -2.02 | |
| % of Revenue | 130.76 | 153.56 | 142.36 | 150.88 | 144.98 |
| Gross Operating Profit | -28 | -35 | -24 | -27 | -25 |
| Change (%) | 22.00 | -30.80 | 13.82 | -9.86 | |
| % of Revenue | -30.76 | -53.56 | -42.36 | -50.88 | -44.98 |
| SG&A | 64 | 46 | 36 | 31 | 31 |
| Change (%) | -29.28 | -21.97 | -12.38 | -1.31 | |
| % of Revenue | 69.75 | 70.39 | 62.78 | 58.05 | 56.19 |
| R&D | |||||
| Change (%) | |||||
| % of Revenue | |||||
| OpEx | 209 | 170 | 133 | 128 | 124 |
| Change (%) | -18.63 | -21.90 | -3.43 | -3.29 | |
| % of Revenue | 226.39 | 262.89 | 234.64 | 239.13 | 226.79 |
| Operating Income | -117 | -105 | -76 | -75 | -69 |
| Change (%) | -9.69 | -27.67 | -2.09 | -7.07 | |
| % of Revenue | -126.39 | -162.89 | -134.64 | -139.13 | -126.79 |
| Interest Expense | -22 | -24 | -20 | -20 | -22 |
| Change (%) | 9.92 | -15.06 | -1.99 | 12.30 | |
| % of Revenue | -23.44 | -36.77 | -35.69 | -36.92 | -40.66 |
| Net Income | -135 | -125 | -85 | -82 | -74 |
| Change (%) | -7.97 | -31.78 | -3.52 | -10.23 | |
| % of Revenue | -146.57 | -192.49 | -150.07 | -152.80 | -134.52 |
Source: Capital IQ
